Hepatitis A virus (HAV) remains enigmatic, despite 1.4 million cases worldwide annually 1 . It differs radically from other picornaviruses, existing in an enveloped form 2 and being unusually stable, both genetically and physically 3 , but has proved difficult to study. Here we report high-resolution X-ray structures for the mature virus and the empty particle. The structures of the two particles are indistinguishable, apart from some disorder on the inside of the empty particle. The full virus contains the small viral protein VP4, whereas the empty particle harbours only the uncleaved precursor, VP0. The smooth particle surface is devoid of depressions that might correspond to receptor-binding sites. Peptide scanning data extend the previously reported VP3 antigenic site 4 , while structure-based predictions 5 suggest further epitopes. HAV contains no pocket factor and can withstand remarkably high temperature and low pH, and empty particles are even more robust than full particles. The virus probably uncoats via a novel mechanism, being assembled differently to other picornaviruses. It utilizes a VP2 'domain swap' characteristic of insect picorna-like viruses 6,7 , and structure-based phylogenetic analysis places HAV between typical picornaviruses and the insect viruses. The enigmatic properties of HAV may reflect its position as a link between 'modern' picornaviruses and the more 'primitive' precursor insect viruses; for instance, HAV retains the ability to move from cell-to-cell by transcytosis 8, 9 .
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HAV is unique among picornaviruses in targeting the liver and continues to be a source of mortality despite a successful vaccine 10 . HAV isolates belong to a single serotype 11 . Unlike other picornaviruses HAV cannot shut down host protein synthesis, has a highly deoptimized codon usage and grows poorly in tissue culture. Particles are produced with a 67-residue carboxy-terminal extension of VP1, which is implicated in particle assembly (this longer form of VP1 is known as VP1-2A or PX) 12 . Particles containing the extension shroud themselves in host membrane to create enveloped viruses 2 . The extension is cleaved by host proteases to yield mature capsids 12 . While picornavirus VP4 is generally myristoylated this does not happen in HAV 13 ; indeed, the putative VP4 is very small (,23 residues 13 ) and it has remained unclear if it is present in virus particles 14 . The cell surface molecule T cell immunoglobulin and mucin 1 (TIM-1) 15 acts as a receptor for HAV, and although transcytosis occurs 8, 9 it is not clear how the virus gets to the liver, its principal site of replication.
We have analysed formaldehyde-inactivated HAV genotype TZ84 (Methods). Two types of particle were separated, one containing significant amounts of viral RNA (Extended Data Fig. 1 ). In the RNAcontaining full particles VP0 is at least partially cleaved and we detect VP4, as for other picornaviruses, whereas the empty particles harbour only VP0, and are probably similar to the empty particles frequently seen in picornavirus infections (Methods and Extended Data Fig. 1 ). It remains unclear whether such empty particles can encapsidate RNA and lie on the route to assembly of full particles. Even full particles appear to contain more uncleaved VP0 than is seen in other picornaviruses, in line with observations that VP0 cleavage is 'protracted' 16 . The sedimentation coefficients are approximately 144S and 82S for the full and empty particles, respectively (Extended Data Fig. 1 ). 144S is a little less than the 155S expected for a full enterovirus particle, while the empty particle has a similar S value to that observed for the more expanded empty enterovirus particles 17 .
Very thin crystals (,100 3 100 3 5 mm 3 ) were obtained for both particles. Diffraction data were collected at Diamond beamlines I03 and I24. Data were collected at 100K to avoid beam-induced crystal movement at room temperature (Supplementary Video 1), and were used to produced reliable atomic models at 3.0 and 3.5 Å resolution for the full and empty particles, respectively (Methods and Extended Data Table 1 ).
The external surface of HAV is smooth, with no canyon ( Fig. 1a ) 18 ; shortening of the VP1 BC loop lowers the north wall while reductions in the VP2 EF and VP1 GH loops ablate the south wall of the canyon (Fig. 1b ). Compared to foot-and-mouth-disease virus, the loops at the five-fold and three-fold axes in HAV are slightly raised, giving the virus the appearance of a facetted triakis icosahedron ( Fig. 1a comprise eight-stranded anti-parallel b-barrels, follow the expected pseudo T 5 3 arrangement (where T is the triangulation number) and span the thickness of the capsid (Extended Data Fig. 2a -c). The HAV full virus is mostly well ordered (however, VP4, although present, is not visible). As expected there is no evidence for structural modification attributable to formaldehyde inactivation 17 . The empty and full particles are mostly very similar, with the external surface expected to be antigenically indistinguishable (r.m.s.d. for 672 Ca atoms 0.2 Å ). Experiments with six antibodies confirmed this (Extended Data Fig. 3 ). The particle surface is remarkably negatively charged ( Fig. 1c ) and the fringes of the pentameric assemblies, which show some positive charge, are decorated with a string of sulphate ions derived from the crystallization media. Surface decoration may affect the hydrodynamic properties of the particles. In the empty particle the first 40 residues of VP0 and 47 residues of VP1, which adorn the particle interior near the three-fold axes, are disordered ( Fig. 1d ). Although neither particle contains the extended form of VP1 we can infer the point on the particle surface from which the extension would continue (Extended Data Fig. 2d ).
Perhaps correlated with the lack of a canyon, HAV harbours no contiguous hydrophobic pocket in the VP1 b-barrel. The b-barrel is compressed compared to enteroviruses 20 and the remaining space is largely filled with hydrophobic side chains, as in aphthoviruses and cardioviruses 21 ( Fig. 2a-c ). In addition, lengthened bC and bH strands essentially cover what would be the entrance to the pocket. We conclude that HAV is unable to bind small molecules in the fashion characteristic of enteroviruses. Unfortunately the particle structure provides no immediate clues as to where the TIM-1 receptor 15 might attach.
The organization of the protein chains broadly mirrors other picornaviruses, except for the amino terminus of VP2. At residue 53 there is a flip in the y torsion angle of the peptide, sending the first 53 residues of VP2 across and then along the interpentamer boundary to interact strongly with the neighbouring pentamer (forming an extra strand on the VP2 b-barrel from the adjacent pentamer; Fig. 2d -g). The switch is only ,5 Å from the icosahedral two-fold axis, so that the net effect is to swap the N-terminal structures, in a way reminiscent of domain swaps observed in certain protein structures 22 . As in those cases, it produces a very similar structure overall, but alters the subunit connectivity so that in HAV adjacent protomers of one pentamer are sewn together via the adjacent pentamer ( Fig. 2f, g) . This arrangement is unprecedented in picornaviruses; however, it occurs in insect picorna-like viruses (for example, cricket paralysis virus (CrPV 6 ); Fig. 2d ).
We found that both empty and full particles were extraordinarily robust compared to other picornaviruses (remaining stable at up to 80 uC and at pH values down to about 2 (ref. 23); Fig. 3a and Extended Data Fig. 4 ). It is established for many picornaviruses that the interface between the 12 pentameric assemblies that comprise the icosahedral capsid determine the particle stability [24] [25] [26] . In this context we questioned whether the stability of HAV might be a consequence of the VP2 domain swap at the pentamer interface, and so analysed the stability of CrPV (Extended Data Fig. 4d ). Although harbouring the same domain swap, CrPV particles showed a stability profile similar to a typical picornavirus. The VP2 switch therefore does not explain the stability; however, the interaction region adjacent to the icosahedral two-fold axes, which separates during the initial stages of enterovirus uncoating 17, 27 , shows tight packing in HAV ( Fig. 3b and Extended Data 
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to that seen in poliovirus, where instability is probably triggered by pocket factor release. HAV achieves this complementarity by matching small residues and tyrosine side chains nestled around the two-fold axis (Extended Data Fig. 5 ). This may contribute to the stability of the HAV particle, while the re-wiring of VP2 may reflect a fundamental difference in the mechanism of genome uncoating in HAV compared to enteroviruses. In contrast the other candidate interface for determining stability, which relates protomers within a pentameric assembly, has similar properties to other picornaviruses (Extended Data Fig. 5 ). We think it unlikely that HAV uses the enterovirus mechanism for genome transfer across the endosomal membrane, via an umbilicus comprising the amphipathic N-terminal helix of VP1, and VP4 membrane pore 28, 29 , although the extremely short VP4 protein has a sequence consistent with the formation of an amphipathic helix. The process of infection comprises two distinct steps: particle entry and genome release. In the first of these, HAV may be taken intact into the cell since it is well established that the virus can pass from cell to cell via transcytosis 8, 9 ; whereas the second stage, the release of the RNA genome, remains unclear, and a specific host factor (perhaps a protease) may be required for particle disassembly. A recent report suggests that HAV harbours tandem YPX 3 L motifs (VP2: Y 144 PHGLL 149 and Y 177 PVWEL 182 ), which are suggested to bind the ALIX component of the ESCRT pathway, allowing the virus to engage the ESCRT complex to facilitate release of enveloped particles via exocytosis 2 . Surprisingly, the residues implicated are buried, making their role unclear unless major conformational rearrangements render them accessible, or if they are accessible on a precursor particle.
The antigenicity of HAV is incompletely characterized, with residues S102, V171, A176 and K221 of VP1 and D70, S71, Q74 and 102-121 of VP3 implicated in neutralizing epitopes 4 . All except K221 of VP1 are proposed to form part of a single site; however, they are separated by 40-50 Å on the particle surface (Extended Data Fig. 6 ). To extend our knowledge, 12 monoclonal antibodies (mAbs) against HAV particles were generated (Extended Data Fig. 7) , one of which, mAb 11, combined excellent neutralizing titre with VP3 western blot activity. On the basis of the particle structure a series of peptides covering all exposed virus surface regions were synthesized and tested against mAb 11. VP3 residues 67-77 and 208-219 (Extended Data Fig. 7 ) reacted mildly. The proximity of these regions on the surface of VP3 (Extended Data Fig. 6 ) suggests that both may contribute to a conformational epitope, an augmented version of that identified previously 4 . To identify further antigenic sites on HAV we applied structure-based predictive methodology 5 , which supports the above findings and suggests that VP2 residues 71 and 198 and VP3 residues 89-96 may comprise additional epitopes (Extended Data Fig. 6 ).
HAV possesses subtle but profound structural differences compared to previously characterized picornaviruses. A structure-based phylogeny (Fig. 4a ) suggests that HAV links classical picornaviruses and the insect picorna-like viruses. Furthermore, the N-terminal domain swap renders VP2 more similar to the homologous VP1 and VP3 proteins (Fig. 4b) , supporting the notion that HAV retains structural and functional features characteristic of primordial picornaviruses, which were akin to presentday insect picorna-like viruses, and that the subsequent acquisition of efficient mechanisms of cell entry allowed the explosion in diversity that characterizes present-day mammalian picornaviruses. 
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METHODS
Particle production and purification. HAV virus genotype TZ84 was used to infect 2BS cells at a multiplicity of infection (MOI) of 0.2 at 33-34 uC. Cells were harvested 4 weeks after infection, lysed by treatment with ice-cold 1% sodium deoxycholate in PBS buffer (pH 7.2) and centrifuged to remove cell debris. The supernatant was passed through a 0.22 mm filter, concentrated with a 100 kDa cutoff concentrator and washed with PBS buffer repeatedly. Virus was inactivated by incubation with formaldehyde (1:2,000 dilution) at 4 uC for 7 days, followed by polyethylene glycol 6000 precipitation, chloroform extraction, differential ultracentrifugation and gel filtration. Crude HAV concentrate (1 mg in PBS buffer pH 7.4) was loaded onto a 15-45% (W/V) sucrose density gradient and centrifuged at 29,000 r.p.m. for 3.5 h in an SW41 rotor at 4 uC. Two sets of fractions were collected and dialysed against PBS buffer (Extended Data Fig. 1a ): one contained empty particles (containing no RNA) and the other virions. The two types of viral particle were further purified by 10-40% (W/V) sucrose density gradient ultracentrifugation at 29,000 r.p.m. for 3 h in an SW41 rotor at 4 uC. The main bands were collected and dialysed against PBS buffer. Biochemical, biophysical and EM analysis. SDS-PAGE for protein analysis used a NuPAGE 4-12% Bis-Tris Gel (Invitrogen) according to the manufacturer's protocol (Extended Data Fig. 1b) . The sedimentation coefficients for the two types of particle were determined using a Beckman XL-I analytical ultracentrifuge at 4 uC (Extended Data Fig. 1c, d) . These results confirmed the two types of HAV particle as full virions containing proteins VP1-4 and RNA and possessing a sedimentation coefficient of 144S and empty particles containing VP0, 1 and 3 with no RNA and a sedimentation coefficient of 82S. Transmission electron microscope. Inactivated purified HAV viral particles were deposited onto a carbon-coated grid for 1 min. Excess sample was removed with filter paper, the grid washed twice with double distilled water and the sample immediately negatively stained for 30 s with 2% phosphotungstic acid (adjusted to pH 7.0 with 1 M KOH). Excess stain was removed, and the sample air-dried and transferred to an FEI Tecnai 20 transmission electron microscope for visualization (Extended Data Fig. 1e, f) . Thermofluor assay. Thermofluor experiments were performed with an MX3005p RT-PCR instrument (Agilent/Stratagene). SYTO9 and SYPRO red (both Invitrogen) were used as fluorescent probes to detect the presence of single-stranded RNA and exposed hydrophobic regions of proteins, respectively 23 . 50-ml reactions were set up in a thin-walled PCR plate (Agilent), containing 0.5-1.0 mg of either virus or empty particles, 5 mM SYTO9 and 3X SYPRO red in pH ranging from 2 to 10 buffer solutions and ramped from 25-99 uC with fluorescence recorded in triplicate at 1 uC intervals. The RNA release (T r ) and melting temperature (T m ) were taken as the minima of the negative first derivative of the RNA exposure and protein denaturation curves, respectively (Extended Data Fig. 4 ). Crystallization and data collection. Full and empty particles were concentrated to 1.5 and 3 mg ml 21 respectively before crystallization in Greiner CrystalQuickX plates using a version of the previously described nanolitre vapour diffusion procedure 31 with 30% MPD and 0.5 M ammonium sulphate as precipitants and 0.1 M HEPES-Na buffer at pH 7.5. Crystals (rectangular plates of dimensions ,100 3 100 3 5 mM) were cryo-protected using solutions containing up to 50% MPD and 20% glycerol depending on the crystal age. Data were collected from frozen crystals (100 K) on beamlines I03 and I24 at Diamond Light Source UK. Diffraction images of 0.1u rotation were recorded on a Pilatus6M detector using beam size from 0.02 3 0.02 mm 2 to 0.08 3 0.06 mm 2 , commensurate with crystal size. Using 1.0-s exposure time and 100% beam transmission, typically 50 useful images could be collected from one position of a crystal. For some larger crystals, data could be collected from two positions. A total of some 200 crystals of both full and empty particles were frozen and tested. 17 empty particle crystals diffracted and gave a data set to 3.5 Å resolution with 68.0% completeness; 32 full virus crystals resulted in a data set to 3.0 Å resolution with 44.4% completeness. Although the data suffered from the large mosaic spread of the crystals, the minimal divergence of the X-ray beam on I03 ameliorated the problem. Structure determination. Data were analysed using HKL2000 32 . The mosaicity differed for the full and empty particle crystals ranging from 0.35u to 0.85u. The data were inevitably very weak with average I/sI of 1.4 for the full particle data set and 3.0 for the empty particle data sets. The structures of both particles were determined by molecular replacement. The space group for the empty particle was P2 1 2 1 2 with unit cell dimensions a 5 366.1 Å , b 5 442.9 Å and c 5 289.0 Å (30 protomers in a crystallographic asymmetric unit). For the full virus, the unit cell dimensions are a 5 291.5 Å , b 5 423.3 Å , c 5 314.8 Å and b 5 100.2u, space group P2 1 with a full particle in asymmetric unit. Phasing used molecular replacement with an FMDV model (Cas of a pentamer, Protein Data Bank accession 1FMD) followed by noncrystallographic symmetry (NCS) averaging and refinement using strict NCS constraints 33 . The full virus was centred at (194.1, 106.1, 85.6) and the empty particle at (0, 221.5, 6.0). For each space group the content of the crystallographic asymmetric unit was subjected to rigid-body refinement, followed by cyclic positional, simulated annealing and B-factor refinement using strict NCS constraints with CNS 33 . Maps were averaged used GAP (D.I.S., J. Grimes and J. Diprose, unpublished) and models were rebuilt with COOT 34 . Refinement of the full particle structure stuck at an R-factor of 31.8%, probably attributable to imperfect isomorphism of the constituent crystals and to the extreme weakness of the data. For statistics, see Extended Data Table 1 . Structural comparisons used SHP 35 . Unless otherwise noted structural figures were prepared with PyMOL 36 . Production of monoclonal antibody and neutralization assay. Groups of 15 adult (4 weeks old) female BALB/c mice were immunized intraperitoneally with 10 mg inactivated HAV virus. All animal procedures were carried out in accordance with the guideline for the Use of Animals in Research issued by the Institute of Biophysics, Chinese Academy of Sciences. Two booster doses were given at 2 weekly intervals. Two weeks after the last immunization, blood samples were obtained from the tail and tested by enzyme-linked immunosorbent assay (ELISA) using purified HAV virus as antigen. Classical protocols for production of monoclonal antibody were followed (continuous cultures of fused cells secreting antibody of predefined specificity). For the neutralization assay, purified monoclonal antibodies at a concentration of 0.2 mg ml 21 were initially diluted eightfold as stocks, and then serially diluted twofold with DMEM containing 2% FBS. 100 ml of twofold antibody dilutions were mixed with 100 ml of HAV virus containing 100 TCID 50 for 1 h at 37 uC, and then added to monolayers of 2BS cells in cell culture flasks (T25 CM 2 ), meanwhile, maintaining medium was provided as well. Each dilution was replicated three times along with one control that contained no serum dilution. After 21 days of growth at 33 uC, the medium was removed and the cells washed three times using PBS buffer, 1 ml of trypsin/EDTA was added and the flask left for 3 min at 37 uC. The suspended cells were freeze-thawed five times to collect the virus. Enzymelinked immunosorbent assay (ELISA) was used to determine neutralizing titre. The titres were read as the highest dilution that gave complete protection. Peptide-ELISA assay. Synthetic peptides spanning the entire exposed region of HAV VP1, VP2 and VP3 capsid proteins were synthesized by Scilight-Peptide Company (Beijing, China). The reactivity of synthetic peptides with purified HAV neutralizing monoclonal antibody was measured by ELISA. Briefly, 96-well plates were coated with 100 ml well 21 of individual peptide (10 mg ml 21 in PBS buffer) at 4 uC overnight. An unrelated EV71 peptide was used as a negative control and inactivated HAV as a positive control. The wells were then incubated sequentially with 100 ml well 21 of PBST plus 5% skimmed milk powder at 37 uC for 1 h, and 100 ml well 21 of HAV neutralizing monoclonal antibodies at the indicated dilutions were incubated at 37 uC for 1 h. Horseradish peroxidase (HRP) conjugated goat antimouse IgG diluted (1:5,000) in PBST plus 1% milk powder was used as secondary antibody at 37 uC for 1 h. Five washes with PBST were carried out between incubation steps. For colour development, 100 ml well 21 of TMB mixture was added and incubated for 10 min, followed by addition of 50 ml well 21 of 1M H 3 PO 4 to stop the reaction. Absorbance was measured at 450 nm in a 96-well plate reader.
Extended Data Figure 1 | HAV purification and characterization.
a, Zonal ultracentrifugation of a 15% to 45% (w/v) sucrose density gradient at 103,614 g for 3.5 h was used to purify HAV, as described in Methods. Two predominant particle types were separated; one was located at ,27% sucrose, the other at ,32% sucrose. The absorbance ratios (l260/l280) were 0.76 for the top band and 1.66 for the bottom band, indicating that the former contained mainly empty particles without the RNA genome and the latter mainly full particles with the RNA genome. respectively. The results appear to show incomplete cleavage of VP0 in the full particles and no VP0 cleavage in the empty particles. c, d, Sedimentation velocity experiments were performed on a Beckman XL-I analytical ultracentrifuge at 20 uC. Samples were loaded into a conventional double-sector quartz cell and mounted in a Beckman four-hole An-60 Ti rotor. Data were collected at 15,000 r.p.m. at a wavelength of 287 nm. Interference sedimentation coefficient distributions were calculated from the sedimentation velocity data using SEDFIT 37 . The full particle has a sedimentation coefficient of 144S and the empty particle 82S. e, f, Negative stain electron microscopy of HAV particles. Particles from the top band in panel a, shown in panel f, suggest that light sedimentation fractions were mainly composed of empty particles. Note that some particles appear to have external features. Panel e shows the heavy particles, which appear to contain viral RNA.
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